The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

The FTC accused the companies of creating a “perverse” drug rebate system that prioritizes insulin from manufacturers sold at a higher list price even when cheaper versions are available.

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The FTC claims CVS Health’s Caremark, Cigna’s ESI, United Health Group’s OptumRx created a “perverse drug rebate system,” resulting in higher insulin list prices. Even when lower list ...

KFF health policy expert Larry Levitt described the FTC action as a "shot across the bow." "Insulin is an extreme case of PBMs (pharmacy benefit managers) extracting bigger and bigger rebates from ...

That, the FTC said, helped PBMs and their group purchasing organizations "line their pockets while certain patients are forced to pay higher out-of-pocket costs" for insulin. Caremark said Friday ...

Optum Rx did not immediately respond to a request for comment. The FTC also pointed a finger at drugmakers on Friday. Insulin makers Eli Lilly & Co. (LLY), Sanofi (SNY)and Novo Nordisk (NVO ...

That, the FTC said, helped PBMs and their group purchasing organizations “line their pockets while certain patients are forced to pay higher out-of-pocket costs” for insulin, which is used by ...